To date, surgery is the only curative treatment option for patients with resectable metastases in the liver and is regarded as standard-of-care. However, recurrence rates remain high, which might partly be explained by the inability of conventional technologies to detect small lesions. Near-infrared fluorescence imaging is able to detect lesions as small as 1 mm, but only if they are localized on or several millimeters below the liver surface. Several studies reported the identification of otherwise undetectable liver tumors using near-infrared fluorescence imaging. Research in the coming years will have to determine if this technology is truly beneficial for patients requiring resection of malignant liver tumors.
CITATION STYLE
Handgraaf, H. J. M., Verbeek, F. P. R., Van de Velde, C. J. H., Hutteman, M., & Vahrmeijer, A. L. (2015). Identification of malignant tumors in the liver. In Fluorescence Imaging for Surgeons: Concepts and Applications (pp. 159–168). Springer International Publishing. https://doi.org/10.1007/978-3-319-15678-1_16
Mendeley helps you to discover research relevant for your work.